New drug on PBS for chronic kidney disease patients

Epworth Nephrologist, Professor Ian Fraser welcomed the Hon. Greg Hunt, Minister for Health, to Epworth Richmond on Thursday 20
December 2018 for the Federal government announcement of the drug Tolvaptan (Brand name Jinarc) being put on the PBS. A number of families affected by genetic kidney disease were present to welcome the announcement that would save them around $23,000 per year and help them live a healthier life.

 

Trial investigator Professor Fraser said that the drug’s effectiveness has been established during the last ten years in two key global studies with Epworth being the number one recruiting site in Australia in both studies. 


“For young adults with this condition, this is a breakthrough.  This is the first drug which has been proven to be of benefit in the inherited condition, Autosomal Dominant Polycystic Kidney Disease (APKD).  APKD effects over one in a thousand people, and commonly leads to kidney failure and dialysis in the mid 50s,” Professor Fraser said. 


Read more about the announcement MinisterHunt announced ​


Photo credit:  by DS Images

​​